These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1606 related items for PubMed ID: 15627368

  • 1. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A, Arion VB, Reisner E, Cebrián-Losantos B, Shova S, Trettenhahn G, Keppler BK.
    Inorg Chem; 2005 Jan 10; 44(1):122-32. PubMed ID: 15627368
    [Abstract] [Full Text] [Related]

  • 2. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
    Reisner E, Arion VB, Guedes da Silva MF, Lichtenecker R, Eichinger A, Keppler BK, Kukushkin VY, Pombeiro AJ.
    Inorg Chem; 2004 Nov 01; 43(22):7083-93. PubMed ID: 15500346
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.
    Cebrián-Losantos B, Reisner E, Kowol CR, Roller A, Shova S, Arion VB, Keppler BK.
    Inorg Chem; 2008 Jul 21; 47(14):6513-23. PubMed ID: 18553904
    [Abstract] [Full Text] [Related]

  • 4. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
    Reisner E, Arion VB, Rufińska A, Chiorescu I, Schmid WF, Keppler BK.
    Dalton Trans; 2005 Jul 21; (14):2355-64. PubMed ID: 15995743
    [Abstract] [Full Text] [Related]

  • 5. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
    Reisner E, Arion VB, Eichinger A, Kandler N, Giester G, Pombeiro AJ, Keppler BK.
    Inorg Chem; 2005 Sep 19; 44(19):6704-16. PubMed ID: 16156629
    [Abstract] [Full Text] [Related]

  • 6. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R, Tamasi G, Defazio S, Corsini M, Zanello P, Messori L, Marcon G, Piccioli F, Orioli P.
    Inorg Chem; 2003 Dec 01; 42(24):8038-52. PubMed ID: 14632524
    [Abstract] [Full Text] [Related]

  • 7. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
    Hotze AC, van der Geer EP, Caspers SE, Kooijman H, Spek AL, Haasnoot JG, Reedijk J.
    Inorg Chem; 2004 Aug 09; 43(16):4935-43. PubMed ID: 15285670
    [Abstract] [Full Text] [Related]

  • 8. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I, Serli B, Zangrando E, Katsaros N, Alessio E.
    Inorg Chem; 2007 Feb 05; 46(3):975-92. PubMed ID: 17257042
    [Abstract] [Full Text] [Related]

  • 9. The remarkable reactivity of high oxidation state ruthenium and osmium polypyridyl complexes.
    Meyer TJ, Huynh MH.
    Inorg Chem; 2003 Dec 15; 42(25):8140-60. PubMed ID: 14658865
    [Abstract] [Full Text] [Related]

  • 10. Hydrocarbon oxidation by beta-halogenated dioxoruthenium(VI) porphyrin complexes: effect of reduction potential (RuVI/V) and C-H bond-dissociation energy on rate constants.
    Che CM, Zhang JL, Zhang R, Huang JS, Lai TS, Tsui WM, Zhou XG, Zhou ZY, Zhu N, Chang CK.
    Chemistry; 2005 Nov 18; 11(23):7040-53. PubMed ID: 16163758
    [Abstract] [Full Text] [Related]

  • 11. Consequences of N,C,N'- and C,N,N'-coordination modes on electronic and photophysical properties of cyclometalated aryl ruthenium(II) complexes.
    Wadman SH, Lutz M, Tooke DM, Spek AL, Hartl F, Havenith RW, van Klink GP, van Koten G.
    Inorg Chem; 2009 Mar 02; 48(5):1887-900. PubMed ID: 19235952
    [Abstract] [Full Text] [Related]

  • 12. Trivalent iron and ruthenium complexes with a redox noninnocent (2-mercaptophenylimino)-methyl-4,6-di-tert-butylphenolate(2-) ligand.
    Roy N, Sproules S, Weyhermüller T, Wieghardt K.
    Inorg Chem; 2009 Apr 20; 48(8):3783-91. PubMed ID: 19361249
    [Abstract] [Full Text] [Related]

  • 13. Valence-state analysis through spectroelectrochemistry in a series of quinonoid-bridged diruthenium complexes [(acac)(2)Ru(mu-L)Ru(acac)(2)](n) (n=+2, +1, 0, -1, -2).
    Ghumaan S, Sarkar B, Maji S, Puranik VG, Fiedler J, Urbanos FA, Jimenez-Aparicio R, Kaim W, Lahiri GK.
    Chemistry; 2008 Apr 20; 14(34):10816-28. PubMed ID: 18924186
    [Abstract] [Full Text] [Related]

  • 14. Structural diversity in supramolecular complexes of MCl(3) (M = As, Sb, Bi) with constrained thio- and seleno-ether ligands.
    Levason W, Maheshwari S, Ratnani R, Reid G, Webster M, Zhang W.
    Inorg Chem; 2010 Oct 04; 49(19):9036-48. PubMed ID: 20812749
    [Abstract] [Full Text] [Related]

  • 15. Ruthenium complexes of thiaporphyrin and dithiaporphyrin.
    Chuang CH, Ou CK, Liu ST, Kumar A, Ching WM, Chiang PC, dela Rosa MA, Hung CH.
    Inorg Chem; 2011 Dec 05; 50(23):11947-57. PubMed ID: 22059653
    [Abstract] [Full Text] [Related]

  • 16. Tetranuclear polybipyridyl complexes of Ru(II) and Mn(II), their electro- and photo-induced transformation into di-mu-oxo Mn(III)Mn(IV) hexanuclear complexes.
    Romain S, Baffert C, Dumas S, Chauvin J, Leprêtre JC, Daveloose D, Deronzier A, Collomb MN.
    Dalton Trans; 2006 Dec 28; (48):5691-702. PubMed ID: 17146534
    [Abstract] [Full Text] [Related]

  • 17. Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.
    Ravera M, Baracco S, Cassino C, Zanello P, Osella D.
    Dalton Trans; 2004 Aug 07; (15):2347-51. PubMed ID: 15278129
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z, Matiková-Mal'arová M, Novotná R, Vančo J, Stěpánková K, Suchý P.
    J Inorg Biochem; 2011 Jul 07; 105(7):937-48. PubMed ID: 21536006
    [Abstract] [Full Text] [Related]

  • 19. Kinetics and mechanisms of the oxidation of iodide and bromide in aqueous solutions by a trans-dioxoruthenium(VI) complex.
    Lam WW, Man WL, Wang YN, Lau TC.
    Inorg Chem; 2008 Aug 04; 47(15):6771-8. PubMed ID: 18597422
    [Abstract] [Full Text] [Related]

  • 20. A straightforward and generalizable synthetic methodology for the synthesis of ruthenium(II) complexes with thioether ligands from either Ru(III) or Ru(0) precursors.
    Maiti BK, Görls H, Klobes O, Imhof W.
    Dalton Trans; 2010 Jun 28; 39(24):5713-20. PubMed ID: 20495720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.